Overview
Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion
Status:
Completed
Completed
Trial end date:
2014-10-01
2014-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Epidemiological study of Ozurdex® in sites treating patients with retinal vein occlusion.Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
AllerganTreatments:
BB 1101
Dexamethasone
Dexamethasone 21-phosphate
Dexamethasone acetate
Criteria
Inclusion Criteria:- Macular oedema due to retinal vein occlusion
Exclusion Criteria:
- Not living in metropolitan France